Baili Biopharmaceutical Co., Ltd.
http://www.baili-pharm.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Baili Biopharmaceutical Co., Ltd.
China Biotech IPOs Remain In Deep Freeze, Hong Kong Fares Better
Amid stricter regulatory reviews of applications for IPOs across all sectors, such offerings in biotech have been in hiatus on the Chinese mainland in 2024 to date. Meanwhile, three bioventures raised a combined $217.8m as they floated on the Hong Kong Stock Exchange in the first half.
China Sets Clinical Trial Record But Starting Studies Can Be Challenging
Antibody-drug conjugates, GLP-1 receptor agonists and cell/gene therapies propelled a big increase in clinical trial registrations in China last year, but why do sponsors sometimes remain reluctant to actually start studies?
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Large Molecule
- Antibodies
- Other Names / Subsidiaries
-
- Biokin Pharmaceutical
- Sichuan Baili Pharmaceutical Co. Ltd.
- SystImmune, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice